Sacramento

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Fibromyalgia2 trials
• High blood pressure1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Pulmonary arterial hypertension1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Axsome Therapeutics, Inc.2 trials
• ACELYRIN Inc.1 trial
• Pulmovant, Inc.1 trial

Running trials

• Enrolling by invitation

  Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia

  NCT07637162· Phase 3· Axsome Therapeutics, Inc.· Source

• Recruiting

  Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

  NCT07398417· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

• Active, not recruiting

  A Study of Mosliciguat in PH-ILD

  NCT06635850· Phase 2· Pulmovant, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fibromyalgia2 recruiting

Closed trials

• Terminated

  Psoriatic Arthritis Study of Izokibep

  NCT05623345· Phase 2/3· ACELYRIN Inc.· Source